Scholars@Duke publication: Moloney KW, Devidas M, Mattano L, Friedman A, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kaden-Lottick N, Loh M, Matloub YH, Marshall DT, Stork L, Raetz EA, Wood B, Winick NJ, Hunger SP, Carroll WL. Excellent event free (EFS) and overall survival (OS) for children with Standard Risk Acule Lymphoblastic Leukemia (SR ALL) despite the absence of a significant impact on outcome with the addition of an Intensified Consolidation: Results of Children’s Oncology Group (COG) AALL0331. American Society of Hematology, New Orleans, LA December 7-10, 2013

Moloney KW, Devidas M, Mattano L, Friedman A, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kaden-Lottick N, Loh M, Matloub YH, Marshall DT, Stork L, Raetz EA, Wood B, Winick NJ, Hunger SP, Carroll WL. Excellent event free (EFS) and overall survival (OS) for children with Standard Risk Acule Lymphoblastic Leukemia (SR ALL) despite the absence of a significant impact on outcome with the addition of an Intensified Consolidation: Results of Children’s Oncology Group (COG) AALL0331. American Society of Hematology, New Orleans, LA December 7-10, 2013. (n.d.).

“Moloney KW, Devidas M, Mattano L, Friedman A, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kaden-Lottick N, Loh M, Matloub YH, Marshall DT, Stork L, Raetz EA, Wood B, Winick NJ, Hunger SP, Carroll WL. Excellent event free (EFS) and overall survival (OS) for children with Standard Risk Acule Lymphoblastic Leukemia (SR ALL) despite the absence of a significant impact on outcome with the addition of an Intensified Consolidation: Results of Children’s Oncology Group (COG) AALL0331. American Society of Hematology, New Orleans, LA December 7-10, 2013,” n.d.

Moloney KW, Devidas M, Mattano L, Friedman A, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kaden-Lottick N, Loh M, Matloub YH, Marshall DT, Stork L, Raetz EA, Wood B, Winick NJ, Hunger SP, Carroll WL. Excellent event free (EFS) and overall survival (OS) for children with Standard Risk Acule Lymphoblastic Leukemia (SR ALL) despite the absence of a significant impact on outcome with the addition of an Intensified Consolidation: Results of Children’s Oncology Group (COG) AALL0331. American Society of Hematology, New Orleans, LA December 7-10, 2013. In.

Moloney KW, Devidas M, Mattano L, Friedman A, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kaden-Lottick N, Loh M, Matloub YH, Marshall DT, Stork L, Raetz EA, Wood B, Winick NJ, Hunger SP, Carroll WL. Excellent event free (EFS) and overall survival (OS) for children with Standard Risk Acule Lymphoblastic Leukemia (SR ALL) despite the absence of a significant impact on outcome with the addition of an Intensified Consolidation: Results of Children’s Oncology Group (COG) AALL0331. American Society of Hematology, New Orleans, LA December 7-10, 2013.

Duke Scholars

Citation